Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells

Neurochemistry International

Volumn 57, Issue 5, 2010, Pages 547-555

  Zhang, Li ^a   Yu, Huixin ^a,b   Zhao, Xincan ^b   Lin, Xiufeng ^a   Tan, Chen ^a   Cao, Guoxian ^a   Wang, Zhengwu ^b  

^a BEIJING HOSPITAL   (China)

^b JIANGNAN UNIVERSITY   (China)

Author keywords

Apoptosis; Beta amyloid; Oxidative stress; Salidroside; SH SY5Y cells

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[25-35]; CASPASE 3; HEME OXYGENASE 1; LACTATE DEHYDROGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PEROXIREDOXIN 1; PROTEIN BAX; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; SALIDROSIDE; STRESS ACTIVATED PROTEIN KINASE; THIOREDOXIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; DRUG INHIBITION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROBLASTOMA CELL; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

AMYLOID BETA-PEPTIDES; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; DNA PRIMERS; FLOW CYTOMETRY; GLUCOSIDES; HEME OXYGENASE-1; HUMANS; L-LACTATE DEHYDROGENASE; MEMBRANE POTENTIALS; MITOCHONDRIAL MEMBRANES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; PHENOLS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SINCALIDE; TRYPAN BLUE;

RHODIOLA ROSEA;

EID: 77956231841     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.06.021     Document Type: Article

References (41)

1. Abe K., Saito H. Amyloid [beta] neurotoxicity not mediated by the mitogen-activated protein kinase cascade in cultured rat hippocampal and cortical neurons. Neurosci. Lett. 2000, 292:1-4.
2. Benzi G., Moretti A. Are reactive oxygen species involved in Alzheimer's disease? Neurobiol. Aging 1995, 16:661-674.
3. Boldogh I., Kruzel M.L. Colostrinin: an oxidative stress modulator for prevention and treatment of age-related disorders. J. Alzheimers Dis. 2008, 13:303-321.
4. Cecchi C., Fiorillo C., Baglioni S., Pensalfini A., Bagnoli S., Nacmias B., Sorbi S., Nosi D., Relini A., Liguri G. Increased susceptibility to amyloid toxicity in familial Alzheimer's fibroblasts. Neurobiol. Aging 2007, 28:863-876.
5. Chae H.Z., Chung S.J., Rhee S.G. Thioredoxin-dependent peroxide reductase from yeast. J. Biol. Chem. 1994, 269:27670-27678.
6. Choi M.-M., Kim E.-A., Hahn H.-G., Dal Nam K., Yang S.-J., Choi S.Y., Kim T.U., Cho S.-W., Huh J.-W. Protective effect of benzothiazole derivative KHG21834 on amyloid [beta]-induced neurotoxicity in PC12 cells and cortical and mesencephalic neurons. Toxicology 2007, 239:156-166.
7. Chong Y.H., Shin Y.J., Lee E.O., Kayed R., Glabe C.G., Tenner A.J. ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J. Biol. Chem. 2006, 281:20315-20325.
8. Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz M.A., Lassota P., Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry 1992, 13:795-808.
9. Garcia-Santos G., Herrera F., Martin V., Rodriguez-Blanco J., Antolin I., Fernandez-Mari F., Rodriguez C. Antioxidant activity and neuroprotective effects of zolpidem and several synthesis intermediates. Free Radic. Res. 2004, 38:1289-1299.
10. Gorman A.M., McGowan A., O'Neill C., Cotter T. Oxidative stress and apoptosis in neurodegeneration. J. Neurol. Sci. 139 Suppl 1996, 45-52.
11. Gruden M.A., Davidova T.B., Malisauskas M., Sewell R.D., Voskresenskaya N.I., Wilhelm K., Elistratova E.I., Sherstnev V.V., Morozova-Roche L.A. Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: autoantibodies to Abeta(25-35) oligomers. S100b and neurotransmitters. J. Neuroimmunol. 2007, 186:181-192.
12. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S.P., Wu J.F., Carney J.M., et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 1995, 65:2146-2156.
13. Ishii T., Kawane T., Taketani S., Bannai S. Inhibition of the thiol-specific antioxidant activity of rat liver MSP23 protein by hemin. Biochem. Biophys. Res. Commun. 1995, 216:970-975.
14. Junttila M.R., Li S.P., Westermarck J. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J. 2008, 22:954-965.
15. Kanupriya, Prasad D., Sai Ram M., Kumar R., Sawhney R.C., Sharma S.K., Ilavazhagan G., Kumar D., Banerjee P.K. Cytoprotective and antioxidant activity of Rhodiola imbricata against tert-butyl hydroperoxide induced oxidative injury in U-937 human macrophages. Mol. Cell. Biochem. 2005, 275:1-6.
16. Karuppagounder S.S., Pinto J.T., Xu H., Chen H.L., Beal M.F., Gibson G.E. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem. Int. 2009, 54:111-118.
17. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch. Neurol. 1985, 42:1097-1105.
18. Kucinskaite A., Briedis V., Savickas A. Experimental analysis of therapeutic properties of Rhodiola rosea L. and its possible application in medicine. Medicina (Kaunas) 2004, 40:614-619.
19. Kuszczyk M., Gordon-Krajcer W., Lazarewicz J.W. Homocysteine-induced acute excitotoxicity in cerebellar granule cells in vitro is accompanied by PP2A-mediated dephosphorylation of tau. Neurochem. Int. 2009, 55:174-180.
20. Li H.X., Sze S.C., Tong Y., Ng T.B. Production of Th1- and Th2-dependent cytokines induced by the Chinese medicine herb. Rhodiola algida, on human peripheral blood monocytes. J. Ethnopharmacol. 2009, 123:257-266.
21. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 2001, 21:8370-8377.
22. Liu Y., Guyton K.Z., Gorospe M., Xu Q., Lee J.C., Holbrook N.J. Differential activation of ERK. JNK/SAPK and P3/CSBP/RK map kinase family members during the cellular response to arsenite. Free Radic. Biol. Med. 1996, 21:771-781.
23. Loo D.T., Copani A., Pike C.J., Whittemore E.R., Walencewicz A.J., Cotman C.W. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:7951-7955.
24. Monji A., Utsumi H., Ueda T., Imoto T., Yoshida I., Hashioka S., Tashiro K., Tashiro N. The relationship between the aggregational state of the amyloid-beta peptides and free radical generation by the peptides. J. Neurochem. 2001, 77:1425-1432.
25. Morita Y., Naka T., Kawazoe Y., Fujimoto M., Narazaki M., Nakagawa R., Fukuyama H., Nagata S., Kishimoto T. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:5405-5410.
26. Nakaso K., Yano H., Fukuhara Y., Takeshima T., Wada-Isoe K., Nakashima K. PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells. FEBS Lett. 2003, 546:181-184.
27. Orrenius S., Zhivotovsky B., Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003, 4:552-565.
28. Pakaski M., Hugyecz M., Santha P., Jancso G., Bjelik A., Domokos A., Janka Z., Kalman J. Capsaicin promotes the amyloidogenic route of brain amyloid precursor protein processing. Neurochem. Int. 2009, 54:426-430.
29. Satoh T., Enokido Y., Aoshima H., Uchiyama Y., Hatanaka H. Changes in mitochondrial membrane potential during oxidative stress-induced apoptosis in PC12 cells. J. Neurosci. Res. 1997, 50:413-420.
30. Selkoe D.J. Alzheimer's disease: genotypes, phenotypes, and treatments. Science 1997, 275:630-631.
31. Selkoe D.J. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 2001, 3:75-80.
32. Takashima A., Honda T., Yasutake K., Michel G., Murayama O., Murayama M., Ishiguro K., Yamaguchi H. Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci. Res. 1998, 31:317-323.
33. Takashima A., Noguchi K., Michel G., Mercken M., Hoshi M., Ishiguro K., Imahori K. Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta. Neurosci. Lett. 1996, 203:33-36.
34. Telford W.G., King L.E., Fraker P.J. Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif. 1991, 24:447-459.
35. Webster B., Hansen L., Adame A., Crews L., Torrance M., Thal L., Masliah E. Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease. J. Neuropathol. Exp. Neurol. 2006, 65:142-151.
36. Wilquet V., De Strooper B. Amyloid-beta precursor protein processing in neurodegeneration. Curr. Opin. Neurobiol. 2004, 14:582-588.
37. Young K.F., Pasternak S.H., Rylett R.J. Oligomeric aggregates of amyloid [beta] peptide 1-42 activate ERK/MAPK in SH-SY5Y cells via the [alpha]7 nicotinic receptor. Neurochem. Int. 2009, 55:796-801.
38. Zhang J., Liu A., Hou R., Jia X., Jiang W., Chen J. Salidroside protects cardiomyocyte against hypoxia-induced death: a HIF-1alpha-activated and VEGF-mediated pathway. Eur. J. Pharmacol. 2009, 607:6-14.
39. Zhang L., Yu H.X., Sun Y., Lin X.F., Chen B., Tan C., Cao G.X., Wang Z.W. Protective effects of salidroside on hydrogen peroxide-induced apoptosis in SH-SY5Y human neuroblastoma cells. Eur. J. Pharmacol. 2007, 564:18-25.
40. Zhao X.Y., Li G.Y., Liu Y., Chai L.M., Chen J.X., Zhang Y., Du Z.M., Lu Y.J., Yang B.F. Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. Br. J. Pharmacol. 2008, 154:105-113.
41. Zhu X., Raina A.K., Lee H.G., Casadesus G., Smith M.A., Perry G. Oxidative stress signalling in Alzheimer's disease. Brain Res. 2004, 1000:32-39.